nodes	percent_of_prediction	percent_of_DWPC	metapath
Astemizole—CYP2J2—Fatty acids—CYP2A7—nicotine dependence	0.127	0.143	CbGpPWpGaD
Astemizole—CYP2J2—Xenobiotics—CYP2A7—nicotine dependence	0.101	0.113	CbGpPWpGaD
Astemizole—Anileridine—OPRM1—nicotine dependence	0.0499	0.47	CrCbGaD
Astemizole—CYP2J2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0421	0.0471	CbGpPWpGaD
Astemizole—CYP2J2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0415	0.0464	CbGpPWpGaD
Astemizole—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.0404	0.0452	CbGpPWpGaD
Astemizole—CYP2J2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0341	0.0381	CbGpPWpGaD
Astemizole—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0335	0.0375	CbGpPWpGaD
Astemizole—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.0292	0.0327	CbGpPWpGaD
Astemizole—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.0261	0.0292	CbGpPWpGaD
Astemizole—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.0208	0.0232	CbGpPWpGaD
Astemizole—CYP2J2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0192	0.0215	CbGpPWpGaD
Astemizole—CYP2J2—Biological oxidations—CYP2A7—nicotine dependence	0.0181	0.0203	CbGpPWpGaD
Astemizole—Pimozide—OPRM1—nicotine dependence	0.0179	0.169	CrCbGaD
Astemizole—CYP2J2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0179	0.02	CbGpPWpGaD
Astemizole—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0168	0.0188	CbGpPWpGaD
Astemizole—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0165	0.0185	CbGpPWpGaD
Astemizole—Fentanyl—OPRM1—nicotine dependence	0.0155	0.146	CrCbGaD
Astemizole—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0136	0.0152	CbGpPWpGaD
Astemizole—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.0136	0.0152	CbGpPWpGaD
Astemizole—Fluspirilene—DRD2—nicotine dependence	0.0131	0.124	CrCbGaD
Astemizole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0121	0.0136	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.012	0.0134	CbGpPWpGaD
Astemizole—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.012	0.0134	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—CHRNB3—nicotine dependence	0.0114	0.0128	CbGpPWpGaD
Astemizole—HRH1—Monoamine GPCRs—DRD2—nicotine dependence	0.0111	0.0124	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—CHRNA6—nicotine dependence	0.0109	0.0121	CbGpPWpGaD
Astemizole—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00983	0.011	CbGpPWpGaD
Astemizole—Pimozide—DRD2—nicotine dependence	0.00982	0.0924	CrCbGaD
Astemizole—HRH1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0093	0.0104	CbGpPWpGaD
Astemizole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00862	0.00964	CbGpPWpGaD
Astemizole—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00851	0.00952	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00799	0.00894	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—GABRA4—nicotine dependence	0.00784	0.00878	CbGpPWpGaD
Astemizole—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00766	0.00857	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—CHRNB4—nicotine dependence	0.00752	0.00842	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00725	0.00812	CbGpPWpGaD
Astemizole—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00722	0.00808	CbGpPWpGaD
Astemizole—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00712	0.00797	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—CHRNA5—nicotine dependence	0.00699	0.00782	CbGpPWpGaD
Astemizole—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00699	0.00782	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—CHRNA3—nicotine dependence	0.0057	0.00638	CbGpPWpGaD
Astemizole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00563	0.0063	CbGpPWpGaD
Astemizole—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00556	0.00622	CbGpPWpGaD
Astemizole—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00554	0.0062	CbGpPWpGaD
Astemizole—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00522	0.00584	CbGpPWpGaD
Astemizole—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00515	0.00576	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—CHRNB2—nicotine dependence	0.00502	0.00561	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00457	0.00512	CbGpPWpGaD
Astemizole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00457	0.00511	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—CHRNA4—nicotine dependence	0.00456	0.0051	CbGpPWpGaD
Astemizole—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00394	0.00441	CbGpPWpGaD
Astemizole—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00371	0.00415	CbGpPWpGaD
Astemizole—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00366	0.0041	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—CYP2A7—nicotine dependence	0.0031	0.00347	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00295	0.00331	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00258	0.00289	CbGpPWpGaD
Astemizole—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00257	0.00288	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00253	0.00283	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00243	0.00272	CbGpPWpGaD
Astemizole—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00239	0.00268	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00235	0.00263	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00214	0.00239	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—FGD1—nicotine dependence	0.00203	0.00227	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	0.00193	0.00216	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—FGD1—nicotine dependence	0.00184	0.00206	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00183	0.00205	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00144	0.00161	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—DRD2—nicotine dependence	0.00139	0.00156	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	0.00139	0.00155	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.00123	0.00138	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	0.00109	0.00122	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—FGD1—nicotine dependence	0.00109	0.00122	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	0.000989	0.00111	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	0.000961	0.00108	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000893	0.000999	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	0.000788	0.000881	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—DRD2—nicotine dependence	0.000715	0.0008	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—WASF2—nicotine dependence	0.000677	0.000757	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000674	0.000754	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—WASF1—nicotine dependence	0.000649	0.000726	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000635	0.00071	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—OPRM1—nicotine dependence	0.000584	0.000654	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—DRD2—nicotine dependence	0.000422	0.000473	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000415	0.000464	CbGpPWpGaD
